Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionEric Lawitz, Robert Flisiak, Manal Abunimeh, et al.Hematological Oncology|July 7, 2023
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian studyMarco Picardi, Claudia Giordano, Elena Vigliar, et al.The American Journal of Gastroenterology|June 5, 2013
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in ItalySavino Bruno, Simone Saibeni, Vincenzo Bagnardi, et al.Journal of Gastroenterology and Hepatology|October 11, 2017
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma CampaniaMaria Guarino, Raffaella Tortora, Giorgio de Stefano, et al.Annals of Hematology|July 16, 2026
Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centersMarco Picardi, Annamaria Vincenzi, Claudia Giordano, et al.Atherosclerosis|April 12, 2017
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort studyFrancesco Angelico, Stefano Ginanni Corradini, Daniele Pastori, et al.Advances in Therapy|May 11, 2022
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST StudyMarkus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.Antiviral Therapy|February 7, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimensNicola Coppola, Stefania De Pascalis, Vincenzo Messina, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2025
ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in ItalyElisabetta Bugianesi, Silvio Buscemi, Patrizia Burra, et al.Pageof 14